Literature DB >> 20065076

Sickle cell disease: primum non nocere (first do no harm).

Mariane de Montalembert, Irene Roberts.   

Abstract

Mesh：

Year:  2010        PMID： 20065076      PMCID： PMC2805744          DOI： 10.3324/haematol.2009.020172

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  19 in total

1.  Newborn screening for sickle cell disease: effect on mortality.

Authors:  E Vichinsky; D Hurst; A Earles; K Kleman; B Lubin
Journal:  Pediatrics       Date:  1988-06       Impact factor: 7.124

2.  Long-term hydroxyurea treatment in children with sickle cell disease: tolerance and clinical outcomes.

Authors:  Mariane de Montalembert; Valentine Brousse; Caroline Elie; Françoise Bernaudin; Junxin Shi; Paul Landais
Journal:  Haematologica       Date:  2006-01       Impact factor: 9.941

3.  Health-related quality of life in children with sickle cell disease: child and parent perception.

Authors:  Julie A Panepinto; Kerry M O'Mahar; Michael R DeBaun; Fausto R Loberiza; J P Scott
Journal:  Br J Haematol       Date:  2005-08       Impact factor: 6.998

4.  Posttraumatic stress disorder in children affected by sickle-cell disease and their parents.

Authors:  Michel Hofmann; Mariane de Montalembert; Bérengère Beauquier-Maccotta; Philippe de Villartay; Bernard Golse
Journal:  Am J Hematol       Date:  2007-02       Impact factor: 10.047

5.  Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke.

Authors:  Douglas J Scothorn; Cynthia Price; Daniel Schwartz; Cindy Terrill; George R Buchanan; Wanda Shurney; Ingrid Sarniak; Robert Fallon; Jen-Yih Chu; Charles H Pegelow; Winfred Wang; James F Casella; Linda S Resar; Brian Berman; Thomas Adamkiewicz; Lewis L Hsu; Kwaku Ohene-Frempong; Kim Smith-Whitley; Donald Mahoney; J Paul Scott; Gerald M Woods; Masayo Watanabe; Michael R Debaun
Journal:  J Pediatr       Date:  2002-03       Impact factor: 4.406

6.  Bone marrow transplantation for sickle cell disease. A study of parents' decisions.

Authors:  E Kodish; J Lantos; C Stocking; P A Singer; M Siegler; F L Johnson
Journal:  N Engl J Med       Date:  1991-11-07       Impact factor: 91.245

7.  Hydroxyurea for treatment of severe sickle cell anemia: a pediatric clinical trial.

Authors:  A Ferster; C Vermylen; G Cornu; M Buyse; F Corazza; C Devalck; P Fondu; M Toppet; E Sariban
Journal:  Blood       Date:  1996-09-15       Impact factor: 22.113

8.  Matched-related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research.

Authors:  Julie A Panepinto; Mark C Walters; Jeanette Carreras; Judith Marsh; Christopher N Bredeson; Robert Peter Gale; Gregory A Hale; John Horan; Jill M Hows; John P Klein; Ricardo Pasquini; Irene Roberts; Keith Sullivan; Mary Eapen; Alina Ferster
Journal:  Br J Haematol       Date:  2007-04-24       Impact factor: 6.998

9.  Pulmonary, gonadal, and central nervous system status after bone marrow transplantation for sickle cell disease.

Authors:  Mark C Walters; Karen Hardy; Sandie Edwards; Thomas Adamkiewicz; James Barkovich; Francoise Bernaudin; George R Buchanan; Nancy Bunin; Roswitha Dickerhoff; Roger Giller; Paul R Haut; John Horan; Lewis L Hsu; Naynesh Kamani; John E Levine; David Margolis; Kwaku Ohene-Frempong; Melinda Patience; Rupa Redding-Lallinger; Irene A G Roberts; Zora R Rogers; Jean E Sanders; J Paul Scott; Keith M Sullivan
Journal:  Biol Blood Marrow Transplant       Date:  2009-10-12       Impact factor: 5.742

10.  Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography.

Authors:  R J Adams; V C McKie; L Hsu; B Files; E Vichinsky; C Pegelow; M Abboud; D Gallagher; A Kutlar; F T Nichols; D R Bonds; D Brambilla
Journal:  N Engl J Med       Date:  1998-07-02       Impact factor: 91.245
View more
  2 in total

1.  Targeted Hydroxyurea Education after an Emergency Department Visit Increases Hydroxyurea Use in Children with Sickle Cell Anemia.

Authors:  Lydia H Pecker; Sarah Kappa; Adam Greenfest; Deepika S Darbari; Robert Sheppard Nickel
Journal:  J Pediatr       Date:  2018-06-29       Impact factor: 4.406

2.  A Child as a Donor for Hematopoietic Stem Cell Transplantation: Bioethical Justification-A Case Study on Sickle Cell Disease.

Authors:  Andrea Z Pereira; Ricardo Hellman; Nelson Hamerschlak; Andrea Kondo; Polianna Mara Rodrigues de Souza; Wilson Leite Pedreira; Luiz Fernando Alves Lima Mantovani; Eduardo Juan Troster; Henrique Grunspun; Marco Aurélio Scarpinella Bueno
Journal:  Case Rep Hematol       Date:  2017-02-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.